How to Separate the Science From the (Jerk) Scientist

A recent toast to James Watson highlights a tolerance for bigotry many want excised from the scientific community.

Written byAnna Azvolinsky
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ISTOCK, USCHOOLSEarlier this month at a genomics meeting at the Cold Spring Harbor Laboratory in New York, all of the attendees gathered in Grace Auditorium, where a large painted portrait of James Watson hangs, for the keynote session. Afterward, they held a brief celebration for Watson himself on the occasion of his 90th birthday. Eric Lander, the director of the Broad Institute of MIT and Harvard, with a glass of champagne in hand, toasted the famed geneticist, saying, he has “inspired all of us to push the frontiers of science to benefit humankind.” The audience clapped.

Tucked discretely within Lander’s toast was a little caveat about the man they were all cheering for: “flawed,” Lander called Watson. It was a cryptic acknowledgement of Watson’s racist and sexist public statements, some made even recently. But for many in the scientific community who watched from the sidelines of social media, Lander’s speech was insufficient in condemning Watson’s ugly views.

The science jerks and bigots should be shunned—no matter if they have a Nobel Prize.

Among the first to respond on Twitter with a scathing criticism of the celebration was Caltech’s Lior Pachter. “That people are willing to celebrate this individual in public was a moment of truth for me of what things actually look like in our community,” he tells The Scientist, “and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies